down arrow

Gland Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,401.40
8.15 (0.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Gland Pharma Ltd stock-summary
stock-summary
Gland Pharma Ltd
Large Cap
Pharmaceuticals & Drugs
Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 16.48 Cr
Number of Shares
16.48 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
07-Jun-2024
16.48
16.48
41200
1
Issued under ESOP Scheme
25-Mar-2024
16.47
16.47
2400
1
Issued under ESOP Scheme
14-Feb-2024
16.47
16.47
6200
1
Issued under ESOP Scheme
10-Oct-2023
16.47
16.47
1100
1
Issued under ESOP Scheme
29-Mar-2023
16.47
16.47
10600
1
Issued under ESOP Scheme
24-Nov-2022
16.47
16.47
1800
0
Issued under ESOP Scheme
24-Nov-2022
16.47
16.47
1800
1
Issued under ESOP Scheme
15-Sep-2022
16.47
16.47
32500
1
Issued under ESOP Scheme
15-Jun-2022
16.47
16.47
79400
1
Issued under ESOP Scheme
29-Apr-2022
16.46
16.46
273800
1
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 22 Schemes (32.37%)

FIIs

Held by 149 FIIs (5.04%)

Promoter with highest holding

Fosun Pharma Industrial Pte. Ltd (51.83%)

Highest Public shareholder

Mirae Asset Large & Midcap Fund (7.52%)

Individual Investors Holdings

3.3%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Yiu Kwan Stanley Lau
Chairman & Independent Directo
57.4 lacs
SRINIVAS SADU
Managing Director & CEO
7.07 cr
QIYU CHEN
Non-Exec & Non-Independent Dir
0
UDO JAHANNES VETTER
Non-Exec & Non-Independent Dir
33.0 lacs
C S N Murthy
Independent Director
33.0 lacs
ESSAJI GOOLAM VAHANVATI
Independent Director
31.0 lacs
Naina Lal Kidwai
Independent Director
1.08 cr
Jia Ai (Allen) Zhang
Non-Exec & Non-Independent Dir
0
Yao Fang
Non-Exec & Non-Independent Dir
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase
25.665
0%
 
100
Purchase
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,384 Cr
(Quarterly Results - Dec 2024)
Net Profit:
205 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 23,089 Cr (Large Cap)

stock-summary
P/E

33.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.44%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

7.87%

stock-summary
Price to Book

2.61

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."